FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to cardiology and laboratory diagnostics, and can be used to stratify the residual inflammatory risk of atherosclerotic cardiovascular diseases by determining the level of highly sensitive C-reactive protein (hsCRP). If the hsCRP level is less than 2 mg/l, the residual inflammatory risk is considered low, and if the hsCRP level is equal to or more than 2 mg/l, it is considered high. When determining the level of hsCRP less than 2 mg/l, the level of the monomeric form of C-reactive protein (mCRP) is additionally determined. If the mCRP value is less than 7 mcg/l, the residual inflammatory risk is assessed as truly low, and if the mCRP value is equal to or more than 7 mcg/l, the risk is assessed as high.
EFFECT: method makes it possible to increase the efficiency and reliability of stratification of the residual inflammatory risk of atherosclerotic cardiovascular diseases by determining the level of highly sensitive CRP and the monomeric form of CRP.
1 cl, 1 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MEASURING CONCENTRATION OF MONOMER C-REACTIVE PROTEIN ON THE SURFACE OF BLOOD CELLS | 2018 |
|
RU2704128C1 |
METHOD FOR RESTENOSIS DEVELOPMENT PREDICTION IN PATIENTS WITH STABLE EXERTIONAL ANGINA FOLLOWING CORONARY STENTING | 2020 |
|
RU2724279C1 |
SORBENT FOR COMBINED REMOVAL FROM HUMAN PLASMA OF ATHEROGENIC LIPOPROTEIDS AND C-REACTIVE PROTEIN | 2019 |
|
RU2700605C1 |
METHOD FOR DETERMINING PROBABILITY OF PRESENCE OF UNSTABLE ATHEROSCLEROTIC PLAQUES IN CORONARY ARTERIES IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | 2017 |
|
RU2665139C1 |
METHOD OF THE EARLY POSTOPERATIVE PERIOD COURSE ESTIMATION IN PATIENTS OPERATED FOR CHRONIC RHEUMATIC HEART DISEASE | 2017 |
|
RU2642600C1 |
METHOD FOR DETERMINING DIAGNOSTIC CRITERION OF VASCULAR WALL STIFFNESS IN PATIENTS SUFFERING ARTERIAL HYPERTENSION ACCOMPANIED BY ABDOMINAL OBESITY | 2014 |
|
RU2567606C1 |
METHOD FOR EARLY DIAGNOSIS OF CHRONIC DISEASES OF THE PARANASAL SINUSES AND PALATINE TONSILS | 2021 |
|
RU2763821C1 |
EARLY DIAGNOSTIC TECHNIQUE FOR ENDOGENOUS INTOXICATION | 2014 |
|
RU2572719C2 |
FORMULATION | 2008 |
|
RU2470628C2 |
METHOD FOR DETECTING THE RISK OF DEVELOPING SYMPTOMATIC CAROTID STENOSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2779063C1 |
Authors
Dates
2022-01-19—Published
2021-07-05—Filed